<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="107422">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01703663</url>
  </required_header>
  <id_info>
    <org_study_id>U037625</org_study_id>
    <nct_id>NCT01703663</nct_id>
  </id_info>
  <brief_title>Nasal EPAP for Stroke Patients With Sleep Apnea: a Pilot Trial.</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <authority>United States: University of Michigan IRBMED.</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Specific aim: To test the effects of nasal expiratory positive airway pressure (EPAP)
      therapy on sleep apnea severity among patients with recent ischemic stroke.

      Hypothesis 1: Ischemic stroke patients with sleep apnea will have less severe sleep apnea,
      as measured by the apnea-hypopnea index (AHI), with nasal EPAP therapy compared with a
      control night.

      Hypothesis 2: Ischemic stroke patients will have higher mean levels of oxygen saturation
      with nasal EPAP therapy compared with a control night.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Apnea-hypopnea index</measure>
    <time_frame>night 1 and night 2</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">18</enrollment>
  <condition>Ischemic Stroke</condition>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>EPAP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Provent Sleep Apnea Therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EPAP</intervention_name>
    <arm_group_label>EPAP</arm_group_label>
    <other_name>Provent Sleep Apnea Therapy.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adults with an ischemic stroke (including TIA with infarction) within the prior 14
             days

        Exclusion Criteria:

          1. Current use of any transnasal tube (eg dobhoff tube)

          2. Current use of CPAP, mechanical ventilation, or supplemental oxygen

          3. Known severe breathing disorders including hypercapnic respiratory failure,
             respiratory muscle weakness, bullous lung disease, bypassed upper airway,
             pneumothorax, pneumomediastinum

          4. Severe heart disease (including severe heart failure)

          5. Pathologically low blood pressure

          6. An acute upper respiratory (including nasal, sinus or middle ear) inflammation or
             infection, or perforation of the ear drum

          7. Sores, abrasions, or skin or mucosal irritation on or around the nose.

          8. Known pregnancy

          9. Inability to provide informed consent

         10. Use of alpha blockers or short acting nitrates

         11. Permanent pacemaker

         12. Sustained non-sinus cardiac arrhythmia
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Devin Brown, MD</last_name>
    <phone>7349269075</phone>
    <email>devinb@umich.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Devin Brown, MD</last_name>
      <phone>734-936-9075</phone>
      <email>devinb@umich.edu</email>
    </contact>
    <investigator>
      <last_name>Devin Brown, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <lastchanged_date>November 28, 2012</lastchanged_date>
  <firstreceived_date>October 5, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Devin Brown</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Sleep Apnea</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
